Trial intelligence / Profile preview

Ibuprofen arginine versus ibuprofen in osteoarthritis patients with stabilized hypertension

2011-003826-28Phase 4Terminated

Sponsor
Zambon
Start
Sep 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of ibuprofen arginine and ibuprofen in osteoarthritis (OA) and hypertension (HTN) (2 arms), sponsored by Zambon. Primary endpoint: Change from baseline in daily spontaneous pain. Started Sep 2012; status: terminated.

02

Drugs

ibuprofen arginineibuprofen
03

Conditions

osteoarthritis (OA)hypertension (HTN)

Beyond the preview

Go deeper on 2011-003826-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003826-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call